Am J Transplant, Volume 21, Suppl 3 Archives - Page 129 of 139 - ATC Abstracts

2021 American Transplant Congress
Relationship Between Tacrolimus Blood Levels and Covid-19 Pandemic in Kidney Transplant Recipients
T. Inoue¹, K. Unagami,², A. Ishiwatari³, T. Kanzawa³, T. Shimizu³, K. Omoto³, M. Inui³, T. Suzuki¹, H. Ishida⁴, K. Tanabe³
¹Department of Nephrology, Kameda Medical Center, Chiba Kamogawa, Japan, ²Department of Organ Transplant Medicine, Tokyo Women’s Medical University, Tokyo, Japan, ³Department of Urology, Tokyo Women’s Medical University, Tokyo, Japan, ⁴Department of Organ transplant medicine, Tokyo Women’s Medical University, Tokyo, Japan
*Purpose: The novel coronavirus 2019 infection (COVID-19) caused a pandemic, prompting Tokyo, Japan, to restrict on the free movement of people in March 2020. Kidney…
2021 American Transplant Congress
PDSA Model to Improve Pneumococcal Vaccine Adherence Among Kidney Transplant Candidates
J. M. Ramakrishna, L. Brumble, C. R. Libertin
Division of Infectious Diseases, Mayo Clinic, Florida, Jacksonville, FL
*Purpose: Streptococcus pneumoniae infections occur in solid organ transplant patients at a rate of 146 per 100,000 persons per year versus 11.5 per 100,000 persons…
2021 American Transplant Congress
Ganciclovir Therapeutic Drug Monitoring in Obese Adults Patients – Opportunity for Clinical Utility
Y. Tran¹, S. Bernard¹, R. W. Stevens¹, L. Myhre¹, R. Razonable²
¹Department of Pharmacy, Mayo Clinic, Rochester, MN, ²Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, MN
*Purpose: Ganciclovir (GCV) is the drug of choice for the treatment of cytomegalovirus (CMV) infection; optimal dosing of GCV in the obese patient population is…
2021 American Transplant Congress
Covid 19 Re-infection versus Re-activation in Two Renal Transplant Patients
L. Liriano-Ward, Y. Al Azzi, R. Bartash, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin
Montefiore Medical Center, New York, NY
*Purpose: Rare cases of potential COVID 19 re-infection have been reported throughout the world.*Methods: We describe two renal transplant recipients with possible SARS-COV-2 re-infection.*Results: Patient…
2021 American Transplant Congress
Impact of Cytomegalovirus Prophylaxis on Herpes Simplex and Varicella Zoster Virus Infections in Kidney Transplant Recipients
K. Ridgely¹, B. Crowther², P. Klem², K. Schoeppler¹, K. Schwarz¹, A. Nadrash², V. Lewis¹, E. Benamu³
¹Department of Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ²Ambulatory Care Pharmacy Services, UCHealth University of Colorado Hospital, Aurora, CO, ³Department of Medicine, UCHealth University of Colorado Hospital, Aurora, CO
*Purpose: To assess the impact of cytomegalovirus (CMV) targeted antiviral prophylaxis on the development of herpes simplex (HSV) and varicella zoster (VZV) infections after kidney…
2021 American Transplant Congress
Low Immunogenic Donors Improved Survival of Kidney Transplants in African American Recipients
D. Bekbolsynov¹, R. Green², B. Mierzejewska¹, O. Ekwenna¹, M. Rees¹, S. Stepkowski¹
¹University of Toledo, Toledo, OH, ²Bowling Green State University, Bowling Green, OH
*Purpose: Kidney transplants fail more often in African American (AA) than in Caucasian (CAU) recipients. We calculated the hydrophobic mismatch score (HMS) from polymorphic amino…
2021 American Transplant Congress
Days of Delayed Graft Function and Its Impact on Graft Outcomes in Deceased Donor Kidney Transplant
P. Budhiraja¹, R. J. Butterfield², S. S. Misra¹, K. S. Reddy³, L. Kodali¹, H. A. Khamash¹, S. Nair¹, G. K. Mour¹, H. A. Chakkera¹, C. C. Jadlowiec³, H. Janna¹, R. L. Heilman¹
¹Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ, ²Department of Statistics, Mayo Clinic Arizona, Phoenix, AZ, ³Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ
*Purpose: There has been controversy regarding impact of delayed graft function (DGF) on risk of acute rejection and graft survival. This is likely due to…
2021 American Transplant Congress
Outcomes in Older Recipients Receiving Kidneys from Donors with Acute Kidney Injury (AKI)
S. Nair, K. Reddy, L. Kodali, P. Budhiraja, J. Ninan, C. Jadlowiec, A. Mathur, J. Harbell, H. Khamash, M. Smith, R. Heilman
Mayo Clinic, Phoenix, AZ
*Purpose: Older patients are perceived to tolerate delayed graft function (DGF) poorly and there is a reluctance to transplant a kidney from an AKI donor…
2021 American Transplant Congress
Greater Social Vulnerability is Associated with Self-advocacy in the Living Donor Navigator Program
A. Carter, A. C. Kale, R. D. Reed, B. A. Shelton, H. Qu, M. C. McLeod, B. J. Orandi, R. M. Cannon, D. Anderson, P. MacLennan, V. Kumar, M. Hanaway, J. E. Locke
University of Alabama at Birmingham Hospital, Birmingham, AL
*Purpose: The Living Donor Navigator (LDN) program helps transplant candidates identify live donors by pairing them with an advocate - a friend or family member…
2021 American Transplant Congress
Transplant Decision Making Concerns for Asian Patients with End-Stage Kidney Disease
N. Singh¹, A. Wasim¹, G. Chawla¹, F. Jamil¹, M. Hamid¹, R. Siddiqui¹, E. Lui¹, N. El-Dassouki¹, M. Novak¹, A. D. Waterman², I. Mucsi¹
¹University Health Network, Toronto, ON, Canada, ²David Geffen School of Medicine, UCLA, Los Angeles, CA
*Purpose: Compared to White Canadians, Asian Canadians with end stage kidney disease (ESKD) are less likely to receive living donor kidney transplant (LDKT). We explored…